At Highnoon Laboratories, profits surge on export growth

Highnoon Laboratories Limited (HINOON), one of Pakistan’s most dynamic pharmaceutical firms, has announced its financial results for the calendar year 2024, revealing a stellar 35% increase in net profit that outpaced revenue growth – a clear signal of growing operating leverage and cost efficiency within the company.

The Lahore-based pharmaceutical company reported a net profit of Rs3.25 billion for CY24, a sharp increase from Rs2.40 billion in the previous year. Earnings per share (EPS) rose from Rs45.35 to Rs61.41, underscoring strong profitability despite a competitive and volatile operating environment.

Highnoon’s revenue from customer contracts climbed to Rs23.3 billion, reflecting a 20% year-on-year increase from Rs19.4 billion in 2023. Gross profit grew by an even steeper 29%, supported by an improved gross margin of 51% – up from 48% in CY23. Analysts attribute this margin uplift to scale-driven efficiencies and strategic cost management in marketing and procurement.

These results suggest Highnoon is now firmly achieving operating leverage. Revenue is rising, but profits are growing faster.

Operationally, Highnoon saw an impressive 48% increase in profit from operations, climbing to Rs4.8 billion. Meanwhile, other income more than doubled, reaching Rs432 million, and despite a near tripling of finance costs, profit before tax rose 47% year-on-year.

To read the full article, subscribe and support independent business journalism in Pakistan

The content in this publication is expensive to produce. But unlike other journalistic outfits, business publications have to cover the very organizations that directly give them advertisements. Hence, this large source of revenue, which is the lifeblood of other media houses, is severely compromised on account of Profit’s no-compromise policy when it comes to our reporting. No wonder, Profit has lost multiple ad deals, worth tens of millions of rupees, due to stories that held big businesses to account.

Hence, for our work to continue unfettered, it must be supported by discerning readers who know the value of quality business journalism, not just for the economy but for the society as a whole.

(Already a subscriber? Click here to login)

• Full Price Subscription Plans

  Click to View

  Not only will you be supporting independent journalism, 25% of the amount from your subscription will be used to subsidise those subscribers who cannot afford the full price of the subscription. As a subscriber you will get full access to exclusive paywalled content, and an ad free reading experience. Yearly full price subscription plans also include a complimentary annual subscription to The Wall Street Journal.

  +

• Subsidised Subscription Plans

  Click to View

  Pay part of the full subscription price, if you cannot afford to pay all of it, and the rest will be subsidised by a full paying subscriber. As a subscriber you will get access to exclusive paywalled content, and an ad free reading experience.

• Free Student Subscriptions

  Click to View

  If you are currently a student, you can claim an already-paid-for digital subscription, courtesy
  

  As a subscriber you will get access to exclusive paywalled content, an ad free reading experience.

   

_{Images are for reference only.Images and contents gathered automatic from google or 3rd party sources.All rights on the images and contents are with their legal original owners.}